Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nurit Persi"'
Autor:
Nathan Dinowitz, Nurit Persi, Aviad Pato, Liron Levin, Orit Berhani-Zipori, Moshe Shahor, Joshua D. Rabinowitz, Frank Cichocki, Julian Adams, Dima Yackoubov, Sherri Cohen, Boaz Buhandler, Amnon Peled, Yona Geffen, Ronit Simantov, Julia Rifman, Amram Ben David, Melanie R. McReynolds, Astar Hailu, Avishai Edri, Vered Caspi, Tracey Lodie, Avi Izraeli, Wenyun Lu
Publikováno v:
Transplantation and Cellular Therapy. 28:S214-S215
Adoptive transfer of NK cells is a promising immunotherapeutic modality, however limited NK cell persistence and proliferation in vivo have historically been barriers to clinical success. Nicotinamide (NAM), an allosteric inhibitor of NAD-dependent e
Autor:
Veronika Bachanova, Amnon Peled, Jeffrey S. Miller, Einat Galamidi, Chana Lador, Esti Olesinski, Tony Peled, Nurit Persi, Efrat Landau, Guy Brachya
Publikováno v:
Blood. 130:657-657
Adoptive transfer of cytolitic Natural Killer (NK) cells is a promising immunotherapeutic modality for hematologic and other malignancies. However, limited NK cell in vivo persistence and proliferation have been challenging clinical success of this t
Autor:
Aviv Regev, Ayelet Rahav, Lion Novak, Nurit Persi, Daniel Rothenstein, Avi Stein, Orna Mor, Yoel Shiboleth, Yoram Mor, Dana Lehavi, Leonid Brodsky, Ofer Nativ, Elena Feinstein, Rami Skaliter, Ada Rozen, Keren Morag, Eva Berent
Publikováno v:
Oncogene. 22:7702-7710
The incidence of transitional cell carcinoma (TCC), the fourth most common neoplasm diagnosed in men, is rising. Despite the development of several noninvasive diagnostic tests, none have gained full recognition by the clinicians. Gene expression pro
Autor:
Amnon Peled, Richard W. Childs, Maria Berg, Toshihiro Onishi, Tony Peled, Nurit Persi, Chana Lador, Ritesh Kotecha, Robert Reger, Luis Espinoza-Calderon, Gabi M. Frei
Publikováno v:
Blood. 122:897-897
Clinical results with NK cells in investigational tumor immunotherapy protocols have at best resulted in partial responses only. The inability of ex vivo expanded NK cells to proliferate in vivo, as well as to home to and be retained in the tumor mic
Publikováno v:
Blood. 118:4035-4035
Abstract 4035 NK cells are cytotoxic lymphocytes that have drawn considerable attention in recent years as a promising tool for immunotherapy in patients with various refractory hematological malignancies and metastatic solid tumors. Clinical results